Genetic and compound screens uncover factors modulating cancer cell response to indisulam

Discovering biomarkers of drug response and finding powerful drug combinations can support the reuse of previously abandoned cancer drugs in the clinic. Indisulam is an abandoned drug that acts as a molecular glue, inducing degradation of splicing factor RBM39 through interaction with CRL4(DCAF15)....

Descripción completa

Detalles Bibliográficos
Autores principales: Pogacar, Ziva, Groot, Kelvin, Jochems, Fleur, Dos Santos Dias, Matheus, Mulero-Sánchez, Antonio, Morris, Ben, Roosen, Mieke, Wardak, Leyma, De Conti, Giulia, Velds, Arno, Lieftink, Cor, Thijssen, Bram, Beijersbergen, Roderick L, Bernards, René, Leite de Oliveira, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095732/
https://www.ncbi.nlm.nih.gov/pubmed/35534224
http://dx.doi.org/10.26508/lsa.202101348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095732/
https://www.ncbi.nlm.nih.gov/pubmed/35534224
http://dx.doi.org/10.26508/lsa.202101348

Ejemplares similares